A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The study aims to demonstrate that intramuscular injection of botulinum toxin with a
paralyzing dose coupled with subcutaneous injection of corticoid has greater efficacy than
corticoid injection only or toxin injection only for treating lateral epicondylitis in
reducing pain at 6 months.
As secondary objectives, the study aims to
- demonstrate improvement of quality of patient's life and positive effect on their
resuming to professional activities or sportive activities.
- evaluate tolerance of treatment by grip strength measurement and adverse event
collection.